Publication | Closed Access

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]

Hematological MalignancyMedicineAcute Myeloid LeukemiaPrognostic ValueHematologyMyeloid NeoplasiaPathologyMixed-phenotype Acute LeukemiaAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyCancer ResearchMinimal Residual DiseaseHealth Sciences